Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104

Oncogene, Published online: 28 February 2020; doi:10.1038/s41388-020-1227-2Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104

Source: Oncogene - February 27, 2020 Category: Cancer & Oncology Authors: Fan Li Ziming Li Qing Han Yirui Cheng Wenxiang Ji Ying Yang Shun Lu Weiliang Xia Source Type: research